Terms: = Bone cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
94 results:
1. Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML.
Kelvin JM; Jain J; Thapa A; Qui M; Birnbaum LA; Moore SG; Zecca H; Summers RJ; Switchenko JM; Costanza E; Uricoli B; Wang X; Jui NT; Fu H; Du Y; DeRyckere D; Graham DK; Dreaden EC
Pharm Res; 2023 Sep; 40(9):2133-2146. PubMed ID: 37704893
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
[TBL] [Abstract] [Full Text] [Related]
3. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages.
Wang J; Jin J; Chen T; Zhou Q
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889217
[TBL] [Abstract] [Full Text] [Related]
4. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer.
Mateu-Sanz M; Ginebra MP; Tornín J; Canal C
Free Radic Biol Med; 2022 Aug; 189():32-41. PubMed ID: 35843475
[TBL] [Abstract] [Full Text] [Related]
5. Surface osteosarcoma: Predictors of outcomes.
Lee SJ; Lans J; Cook SD; Chebib I; Schwab JH; Raskin KA; Lozano-Calderón S
J Surg Oncol; 2021 Sep; 124(4):646-654. PubMed ID: 34043244
[TBL] [Abstract] [Full Text] [Related]
6. Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy.
Cui L; Huang J; Zhan Y; Qiu N; Jin H; Li J; Huang H; Li H
Life Sci; 2021 Jul; 276():119392. PubMed ID: 33774021
[TBL] [Abstract] [Full Text] [Related]
7. Polymorphism of
Yang Y; Jia J; Sun Z; Liu C; Li Z; Xiao Y; Yu J; Du F; Shi Y; Sun J; Shui J; Zhang X
Future Oncol; 2021 Jun; 17(18):2351-2363. PubMed ID: 33709789
[TBL] [Abstract] [Full Text] [Related]
8. SMAR1 attenuates the stemness of osteosarcoma cells via through suppressing abcg2 transcriptional activity.
Xu H; Liu T; Li W; Yao Q
Environ Toxicol; 2021 Jun; 36(6):1090-1098. PubMed ID: 33543840
[TBL] [Abstract] [Full Text] [Related]
9. High expression of abcg2 is associated with chemotherapy resistance of osteosarcoma.
Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
[TBL] [Abstract] [Full Text] [Related]
10. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells.
Kihira K; Chelakkot VS; Kainuma H; Okumura Y; Tsuboya N; Okamura S; Kurihara K; Iwamoto S; Komada Y; Hori H
Int J Hematol; 2020 Dec; 112(6):795-806. PubMed ID: 32862292
[TBL] [Abstract] [Full Text] [Related]
11. Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
Barr EK; Laurie K; Wroblewski K; Applebaum MA; Cohn SL
Pediatr Blood Cancer; 2020 Oct; 67(10):e28390. PubMed ID: 32710697
[TBL] [Abstract] [Full Text] [Related]
12. Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model.
Curtaz CJ; Schmitt C; Herbert SL; Feldheim J; Schlegel N; Gosselet F; Hagemann C; Roewer N; Meybohm P; Wöckel A; Burek M
Fluids Barriers CNS; 2020 Apr; 17(1):31. PubMed ID: 32321535
[TBL] [Abstract] [Full Text] [Related]
13. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
[TBL] [Abstract] [Full Text] [Related]
14. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
Hu X; Chen F
Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
[No Abstract] [Full Text] [Related]
15. The role of TNF-α in chordoma progression and inflammatory pathways.
Gulluoglu S; Tuysuz EC; Sahin M; Yaltirik CK; Kuskucu A; Ozkan F; Dalan AB; Sahin F; Ture U; Bayrak OF
Cell Oncol (Dordr); 2019 Oct; 42(5):663-677. PubMed ID: 31175552
[TBL] [Abstract] [Full Text] [Related]
16. Uncoupling Warburg effect and stemness in CD133
Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
[TBL] [Abstract] [Full Text] [Related]
17. Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
Macauda A; Castelli E; Buda G; Pelosini M; Butrym A; Watek M; Kruszewski M; Vangsted AJ; Rymko M; Jamroziak K; Abildgaard N; Haastrup EK; Mazur G; Ríos R; Jurczyszyn A; Zawirska D; Dudziński M; Raźny M; Dutka M; Tomczak W; Suska A; Druzd-Sitek A; Marques H; Petrini M; Markiewicz M; Martinez-Lopez J; Ebbesen LH; Iskierka-Jażdżewska E; Sainz J; Canzian F; Campa D
Br J Haematol; 2018 Nov; 183(3):375-384. PubMed ID: 30079960
[TBL] [Abstract] [Full Text] [Related]
18. Correlation of IGF1R expression with abcg2 and CD44 expressions in human osteosarcoma.
Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
[TBL] [Abstract] [Full Text] [Related]
19. A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.
Lui G; Treluyer JM; Fresneau B; Piperno-Neumann S; Gaspar N; Corradini N; Gentet JC; Marec Berard P; Laurence V; Schneider P; Entz-Werle N; Pacquement H; Millot F; Taque S; Freycon C; Lervat C; Le Deley MC; Mahier Ait Oukhatar C; Brugieres L; Le Teuff G; Bouazza N;
J Clin Pharmacol; 2018 Dec; 58(12):1541-1549. PubMed ID: 29791011
[TBL] [Abstract] [Full Text] [Related]
20. Activation of AhR with nuclear IKKα regulates cancer stem-like properties in the occurrence of radioresistance.
Yan B; Liu S; Shi Y; Liu N; Chen L; Wang X; Xiao D; Liu X; Mao C; Jiang Y; Lai W; Xin X; Tang CE; Luo D; Tan T; Jia J; Liu Y; Yang R; Huang J; Zhou H; Cheng Y; Cao Y; Yu W; Muegge K; Tao Y
Cell Death Dis; 2018 May; 9(5):490. PubMed ID: 29706625
[TBL] [Abstract] [Full Text] [Related]
[Next]
